BIOLASE Inc Share Price Nasdaq
Equities
US0909111082
Advanced Medical Equipment & Technology
Sales 2024 * | 51.5M 4.1B | Sales 2025 * | 55.5M 4.42B | Capitalization | 5.04M 402M |
---|---|---|---|---|---|
Net income 2024 * | -8M -638M | Net income 2025 * | -5M -398M | EV / Sales 2024 * | 0.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.09 x |
P/E ratio 2024 * |
-0.47
x | P/E ratio 2025 * |
-1.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.67% |
Latest transcript on BIOLASE Inc
Managers | Title | Age | Since |
---|---|---|---|
John Beaver
CEO | Chief Executive Officer | 62 | 30/09/17 |
Director of Finance/CFO | 53 | 31/01/21 | |
Steven Sandor
COO | Chief Operating Officer | 44 | 31/03/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Lord
CHM | Chairman | 69 | 31/07/14 |
John Beaver
CEO | Chief Executive Officer | 62 | 30/09/17 |
Director/Board Member | 73 | 15/08/21 |
1st Jan change | Capi. | |
---|---|---|
+8.69% | 220B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 107B | |
-0.46% | 63.05B | |
+12.72% | 51.74B | |
+3.96% | 50.47B | |
+0.40% | 40.91B | |
+15.03% | 40.59B |